Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03626246 · ClinicalTrials.gov registry record
Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 50
- Enrollment target
NCT03626246 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 50 participants.
The verdict
NCT03626246 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Kidney disease patients have a variety of bone disorders that result in bone loss and fractures. The mechanisms of these bone disorders are not clear but may be related to abnormal modification of a bone protein known as collagen. Therefore, the investigators are conducting this research study to identify underlying mechanisms that are responsible for the disruption of bone collagen and determining whether the abnormal bone collagen impairs bone strength. The investigators intend to identify these mechanisms through studying relationships between kidney disease and bone strength via bone imaging, bone biopsy and non-invasive measures from blood and skin.
Interventions
- OTHER Kidney disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2020-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03626246
The ClinicalTrials.gov registry entry for NCT03626246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kidney disease is the first listed.
NCT03626246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03626246 about?
NCT03626246 is a clinical study titled "Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease". Kidney disease patients have a variety of bone disorders that result in bone loss and fractures. The mechanisms of these bone disorders are not clear but may be related to abnormal modification of a bone protein known as collagen. Therefore, the investigators are conducting this research study to id...
What is the current status of trial NCT03626246?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-07-01. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03626246?
The interventions under investigation include: Kidney disease (OTHER).
Who is sponsoring clinical trial NCT03626246?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.